Tatva Chintan Pharma Chem Ltd

NSE: TATVA · BSE: 543321 · Chemicals & Petrochemicals · 9 announcements

Share price: ₹1,793.20
Market cap: ₹4,195 Cr
Revenue (annual): ₹505.9 Cr
Net profit (annual): ₹42.05 Cr
P/E (TTM): 81.6×Sector 37.5×
Promoter holding: 72.02%+0.00% QoQ
FII holding: 3.93%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 6 Financial Results 1 Credit Rating 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

8 Sep 2026 17:16 IST NSE

Credit Rating

Tatva Chintan Pharma Chem Credit Rating

CRISIL Ratings upgraded Tatva Chintan's long-term bank facilities to CRISIL A-/Stable and short-term facilities to CRISIL A2+. This upgrade reflects the company's improved credit profile.

Read the filing ↗